
Paramètres
En savoir plus sur le livre
To mitigate the environmental impact of chemical production and reduce reliance on finite fossil resources, whole-cell biocatalysis emerges as a sustainable alternative. However, the apolar nature of target compounds often hinders biocatalyst efficiency due to toxic effects on enzymes and microorganisms. This research evaluates solvent-tolerant P. taiwanensis VLB120 as a biocatalyst to enhance the economic and ecological viability of producing asymmetric (S)-styrene oxide. It integrates biocatalyst development with reaction and process engineering, focusing on critical aspects and potential synergies from varying environments and design goals. A regulatory mutant, P. taiwanensis VLB120∆C∆ttgV, was engineered for constitutive solvent tolerance, eliminating the need for unproductive solvent-adaptation phases and doubling the specific styrene epoxidation activity of resting cells. Under glucose excess conditions, the highest specific styrene epoxidation rates (180 U gCDW-1) were achieved in a two-liquid phase biotransformation setup. The constitutive solvent tolerance also enabled a reduction in extractive organic phase volume by up to 90%, addressing significant environmental and economic concerns. Detailed analysis of glucose metabolism and solvent tolerance led to the identification of additional biocatalyst and process design objectives and engineering strategies.
Achat du livre
Strain and process engineering to exploit solvent tolerance mechanisms of Pseudomonas taiwanensis VLB120 for asymmetric styrene epoxidation, Jan Volmer
- Langue
- Année de publication
- 2016
Modes de paiement
Personne n'a encore évalué .